These data imply that the diminished impact of diabetes on the apoptotic processes as a result of the treatment with C66 is associated with overexpression of MT, which could be related to the overall control of the JNK signaling, however, whether MT directly inhibits JNK phosphorylation, is not clear yet. This evidence concerns the gene MCAT and diabetes mellitus.